Home »
Rulemaking » Prospective Grant of Exclusive License: Development of Therapeutics for Use in Humans to Induce Tolerance for Transplantation and to Treat T cell Lymphoma and Leukemia, etc.
Prospective Grant of Exclusive License: Development of Therapeutics for Use in Humans to Induce Tolerance for Transplantation and to Treat T cell Lymphoma and Leukemia, etc.
Prospective Grant of Exclusive License: Development of Therapeutics for Use in Humans to Induce Tolerance for Transplantation and to Treat T cell Lymphoma and Leukemia, etc.
Details Information
Comments
Related Documents